AIMS Medical Outcomes Study (AMOS)

Advanced Integrative Medical Science Institute

Status: Enrolling

Conditions: Chronic Disease; PTSD; Mental Health Issue; Chronic Pain; Pain

Study type: Observational

Funder types: Other

Identifiers

NCT04512755

AMOS

Details and patient eligibility

About

This epidemiologic research is being conducted as an observational prospective case series outcomes study of the use of advanced integrative specialty medical care and its effect on adult and pediatric patients with chronic or serious illnesses or mental health disorders.

Full description

There is growing interest in providing integrative medical care in conjunction with specialty medical care to expand the reach of integrative care to more chronically and seriously ill patient populations. At the AIMS Institute, the core specialties are naturopathy, palliative care, psychiatry, physiatry, and naturopathic oncology practiced via coordinated, team-based care by allopathic medical and psychiatric specialists, psychotherapists, specialized naturopathic physicians, advanced practice nurses, and targeted health educators, with the majority of care covered by insurance. Additionally incorporated are novel 'advanced' approaches, such as drug-assisted psychotherapy, medical cannabis education, sympathetic blocks, and some intravenous therapies.

This is an uncontrolled, prospective case series outcomes study of health-related quality of life outcomes in patients who receive care at AIMS Institute. A clinic-wide chart audit of patient characteristics and outcomes will be conducted prior to the start of enrollment.

Enrollment: 500 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients enrolled in the study will meet the following criteria:

  1. A new patient coming in for a first office call (FOC) or first consultation via telemedicine with an AIMS physician or advanced practice provider;
  2. An established patient;
  3. If over 18 years of age are able to understand study design adequately and provide signed informed consent to enrollment;
  4. If younger than 18 years of age informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient.

Exclusion criteria

• Ineligible participants:

  1. Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires;
  2. Unwilling to participate in the AIMS Institute observational study.